Skip to main content

Mark Klimek

By Mark Klimek | 03:27 pm | February 06, 2020
Eleven drugs are potential blockbusters with an expected $1 billion in U.S. sales, according to the report.
By Mark Klimek | 01:44 pm | September 17, 2019
To date, attacks that have led to patient data being exposed; Going forward, attackers will seek to disrupt hospitals' operations, Moody's says.
By Mark Klimek | 04:47 pm | July 12, 2019
The device is a significant departure from traditional surgical treatments for sleep apnea.
By Mark Klimek | 03:47 pm | July 02, 2019
New approach seeks to improve lifestyle choices and outcomes by steering members toward "best fit" health apps and providers.
By Mark Klimek | 01:04 pm | June 04, 2019
Premiums for employer-sponsored insurance plans over the last 10 years rose 55 percent, twice as fast as workers' earnings.
By Mark Klimek | 04:27 pm | May 28, 2019
Insurers miss the mark when it comes to member expectations for the kind of consumer experiences they get from other industries.
By Mark Klimek | 06:50 pm | May 22, 2019
The strategy can carry credit risks, because when hospitals stray from their core competencies, they may strain their financial health, Moody's says.
By Mark Klimek | 03:24 pm | May 20, 2019
This is the first time Civica Rx is producing generic drugs since the company was launched last year by the Mayo Clinic, Intermountain, HCA and others.
By Mark Klimek | 11:08 am | May 16, 2019
Anthem last year was required to pay $16 million in the most costly HIPAA fine ever, for what remains the largest data breach for the industry.
By Mark Klimek | 01:32 pm | May 09, 2019
Operations continue, wages are unaffected and none of the health system's three hospitals or other care centers will close, Astria says.